Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-07-22
2008-07-22
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S183000
Reexamination Certificate
active
11475808
ABSTRACT:
The invention relates to at least one pyrrolotriazine derivative, at least one pharmaceutical composition comprising at least one pyrrolotriazine derivative, and at least one method of using at least one pyrrolotriazine derivative to treat at least one kinase associated condition.
REFERENCES:
patent: 6670357 (2003-12-01), Leftheris et al.
patent: 6869952 (2005-03-01), Perry
patent: 6916815 (2005-07-01), Vite et al.
patent: 6951859 (2005-10-01), Bhide et al.
patent: 6969717 (2005-11-01), Bhide et al.
patent: 6982265 (2006-01-01), Hunt et al.
patent: 7102002 (2006-09-01), Cai et al.
patent: 2004/0082582 (2004-04-01), Dyckman et al.
patent: 2006/0004006 (2006-01-01), Borzilleri et al.
patent: WO00/71129 (2000-11-01), None
patent: WO02/40486 (2002-05-01), None
patent: WO2004/009784 (2004-01-01), None
patent: WO2004/013145 (2004-02-01), None
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition, vol. 1, 1004-1010, 1996.
Mass, R. D., Int. J. Radiation Oncology Bio. Phys.vol. 58(3): 932-940, 2004.
Fabbro et al. Pharmacology & therapeutics 93, 79-98, 2002.
U.S. Appl. No. 60/740,704, filed Nov. 30, 2005, Bristol-Myers Squibb Company.
U.S. Appl. No. 11/475,816, filed Jun. 27, 2006, Bristol-Myers Squibb Company.
Chen Ping
Gavai Ashvinikumar V.
Norris Derek J.
Balasubramanian Venkataraman
Bristol--Myers Squibb Company
Fitzpatrick ,Cella, Harper & Scinto
LandOfFree
Pyrrolotriazine compounds useful as kinase inhibitors and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolotriazine compounds useful as kinase inhibitors and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolotriazine compounds useful as kinase inhibitors and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3957094